Bukić, J.; Herceg, D.; Modun, D.; Krce, I.; Leskur, D.; Durdov, T.; Herceg, M.; Šešelja Perišin, A.; Rušić, D.
Evaluating Adverse Drug Reactions, Their Reporting Rates and Their Impact on Attitudes Toward Pharmacotherapy Among Female Patients with Schizophrenia: Insights and Implications from a Cross-Sectional Study. Healthcare 2024, 12, 2595.
https://doi.org/10.3390/healthcare12242595
AMA Style
Bukić J, Herceg D, Modun D, Krce I, Leskur D, Durdov T, Herceg M, Šešelja Perišin A, Rušić D.
Evaluating Adverse Drug Reactions, Their Reporting Rates and Their Impact on Attitudes Toward Pharmacotherapy Among Female Patients with Schizophrenia: Insights and Implications from a Cross-Sectional Study. Healthcare. 2024; 12(24):2595.
https://doi.org/10.3390/healthcare12242595
Chicago/Turabian Style
Bukić, Josipa, Dora Herceg, Darko Modun, Ivana Krce, Dario Leskur, Toni Durdov, Miroslav Herceg, Ana Šešelja Perišin, and Doris Rušić.
2024. "Evaluating Adverse Drug Reactions, Their Reporting Rates and Their Impact on Attitudes Toward Pharmacotherapy Among Female Patients with Schizophrenia: Insights and Implications from a Cross-Sectional Study" Healthcare 12, no. 24: 2595.
https://doi.org/10.3390/healthcare12242595
APA Style
Bukić, J., Herceg, D., Modun, D., Krce, I., Leskur, D., Durdov, T., Herceg, M., Šešelja Perišin, A., & Rušić, D.
(2024). Evaluating Adverse Drug Reactions, Their Reporting Rates and Their Impact on Attitudes Toward Pharmacotherapy Among Female Patients with Schizophrenia: Insights and Implications from a Cross-Sectional Study. Healthcare, 12(24), 2595.
https://doi.org/10.3390/healthcare12242595